This is not a Wikipedia article: It is an individual user's work-in-progress page, and may be incomplete and/or unreliable. For guidance on developing this draft, see Wikipedia:So you made a userspace draft. Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL |
Sigma-2 Receptor new article content ...
References
edit[1] [2] [3] [4] [5] [6] [7] [8] [9]
- ^ van Waarde, A., Rybczynska, A.A., et al. “Sigma Receptors in Oncology: Therapeutic and Diagnostic Applications of Sigma Ligands”
- ^ Hashimoto, K., Ishiwata, K. “Sigma Receptor Ligands: Possible Application as Therapeutic Drugs and as Radiopharmaceuticals”
- ^ van Waarde, A., Rybczynska, A.A., et al. “Potential applications for sigma receptor ligands in cancer diagnosis and therapy”
- ^ Narayana, S., Bhat, R., et al. “Early Development of Sigma-Receptor Ligands”.
- ^ Skuza, G. “Potential Antidepressant Activity of Sigma Ligands”
- ^ Huang, Y., Lu, H., et al. “Sigma-2 Receptor Ligands and Their Perspectives in Cancer Diagnosis and Therapy.”
- ^ Ahmed, I.S.A., Chamberlain, C., Craven, R.J., “S2RPgrmc1: the cytochrome-related sigma-2 receptor that regulates lipid and drug metabolism and hormone signaling”
- ^ Damaskos, C., Karatzas, T., et al. “Nuclear Receptors in Pancreatic Tumor Cells”
- ^ Skuza, G. “Pharmacology of Sigma Receptor Ligand from a Behavioral Perspective”
External links
edit